Literature DB >> 28619963

In Rotterdam, size really does matter: implications of pulmonary artery enlargement on mortality.

Aline N Zouk1,2, J Michael Wells3,2,4.   

Abstract

Entities:  

Mesh:

Year:  2017        PMID: 28619963      PMCID: PMC6011227          DOI: 10.1183/13993003.00750-2017

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  30 in total

1.  Computed tomographic measurement of airway remodeling and emphysema in advanced chronic obstructive pulmonary disease. Correlation with pulmonary hypertension.

Authors:  Gaël Dournes; François Laurent; Florence Coste; Claire Dromer; Elodie Blanchard; François Picard; Fabien Baldacci; Michel Montaudon; Pierre-Olivier Girodet; Roger Marthan; Patrick Berger
Journal:  Am J Respir Crit Care Med       Date:  2015-01-01       Impact factor: 21.405

2.  Pulmonary artery diameter to predict pulmonary hypertension in pulmonary sarcoidosis.

Authors:  Marloes P Huitema; Marcela Spee; Veronique M M Vorselaars; Sanne Boerman; Repke J Snijder; Hendrik W van Es; Herre J Reesink; Jan C Grutters; Marco C Post
Journal:  Eur Respir J       Date:  2015-10-22       Impact factor: 16.671

3.  Pulmonary hypertension in COPD: epidemiology, significance, and management: pulmonary vascular disease: the global perspective.

Authors:  Omar A Minai; Ari Chaouat; Serge Adnot
Journal:  Chest       Date:  2010-06       Impact factor: 9.410

4.  Exercise pathophysiology in patients with primary pulmonary hypertension.

Authors:  X G Sun; J E Hansen; R J Oudiz; K Wasserman
Journal:  Circulation       Date:  2001-07-24       Impact factor: 29.690

5.  Mortality risk as a function of the ratio of pulmonary trunk to ascending aorta diameter in patients with suspected coronary artery disease.

Authors:  Rine Nakanishi; Jamal S Rana; Aryeh Shalev; Heidi Gransar; Sean W Hayes; Troy M Labounty; Damini Dey; Romalisa Miranda-Peats; Louise E J Thomson; John D Friedman; Aiden Abidov; James K Min; Daniel S Berman
Journal:  Am J Cardiol       Date:  2013-02-14       Impact factor: 2.778

6.  Sildenafil to improve respiratory rehabilitation outcomes in COPD: a controlled trial.

Authors:  Isabel Blanco; Salud Santos; Joaqím Gea; Rosa Güell; Ferran Torres; Elena Gimeno-Santos; Diego A Rodriguez; Jordi Vilaró; Begona Gómez; Josep Roca; Joan Albert Barberà
Journal:  Eur Respir J       Date:  2013-02-21       Impact factor: 16.671

7.  One-shot diagnostic and prognostic assessment in intermediate- to high-risk acute pulmonary embolism: the role of multidetector computed tomography.

Authors:  Rui Baptista; Inês Santiago; Elisabete Jorge; Rogério Teixeira; Paulo Mendes; Luís Curvo-Semedo; Graça Castro; Pedro Monteiro; Filipe Caseiro-Alves; Luís A Providência
Journal:  Rev Port Cardiol       Date:  2012-12-11       Impact factor: 1.374

8.  Sildenafil treatment in COPD does not affect stroke volume or exercise capacity.

Authors:  H Rietema; S Holverda; H J Bogaard; J T Marcus; H J Smit; N Westerhof; P E Postmus; A Boonstra; A Vonk-Noordegraaf
Journal:  Eur Respir J       Date:  2007-12-19       Impact factor: 16.671

Review 9.  The emerging role of magnetic resonance imaging in the diagnosis and management of pulmonary hypertension.

Authors:  Gabor Kovacs; Gert Reiter; Ursula Reiter; Rainer Rienmüller; Andrew Peacock; Horst Olschewski
Journal:  Respiration       Date:  2008-11-12       Impact factor: 3.580

10.  Pulmonary artery size as a predictor of outcomes in idiopathic pulmonary fibrosis.

Authors:  Stephanie Shin; Christopher S King; Nitin Puri; Oksana A Shlobin; A Whitney Brown; Shahzad Ahmad; Nargues A Weir; Steven D Nathan
Journal:  Eur Respir J       Date:  2016-02-04       Impact factor: 16.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.